Searching the RRID Resource Information Network
Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.
SciCrunch Registry is a curated repository of scientific resources, with a focus on biomedical resources, including tools, databases, and core facilities - visit SciCrunch to register your resource.
| Resource Name | Proper Citation | Abbreviations | Resource Type |
Description |
Keywords | Resource Relationships | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
DTU Center for Biological Sequence Analysis Resource Report Resource Website 1000+ mentions |
DTU Center for Biological Sequence Analysis (RRID:SCR_003590) | CBS, DTU CBS | analysis service resource, data access protocol, production service resource, service resource, software resource, web service | Center for Biological Sequence Analysis of the Technical University of Denmark conducts basic research in the field of bioinformatics and systems biology and directs its research primarily towards topics related to the elucidation of the functional aspects of complex biological mechanisms. A large number of computational methods have been produced, which are offered to others via WWW servers. Several data sets are also available. The center also has experimental efforts in gene expression analysis using DNA chips and data generation in relation to the physical and structural properties of DNA. The on-line prediction services at CBS are available as interactive input forms. Most of the servers are also available as stand-alone software packages with the same functionality. In addition, for some servers, programmatic access is provided in the form of SOAP-based Web Services. The center also educates engineering students in biotechnology and systems biology and offers a wide range of courses in bioinformatics, systems biology, human health, microbiology and nutrigenomics. | nucleotide, sequence, amino acid, dna, microarray, molecule, immunology, protein function, protein structure, protein, post-translational, whole genome, sequence analysis |
has parent organization: Technical University of Denmark; Lyngby; Denmark is parent organization of: NESbase is parent organization of: O-GLYCBASE is parent organization of: OligoWiz is parent organization of: SignalP |
Danish National Research Foundation ; Danish Research Councils ; Danish Center for Scientific Computing ; Villum Kann Rasmussen Foundation ; Novo Nordisk Foundation ; European Union ; NIH |
nlx_12329 | http://www.cbs.dtu.dk/index.shtml | SCR_003590 | SciCrunch Registry | 2026-09-26 02:13:30 | 1475 | |||||||
|
Comprehensive Biomarker Center Resource Report Resource Website |
Comprehensive Biomarker Center (RRID:SCR_003901) | CBC | commercial organization | Commercial organization that discovers, validates & analyzes genomic biomarkers with a focus on body fluid samples. Take advantage of their proven expertise in biomarker signature development and speed up your biomarker studies. | biomarker, clinical research organization, genomic biomarker, genomic, diagnostic, testing, bodily fluid, clinical, dna, rna, dna extraction, rna extraction, microarray, next-generation sequencing, validation, microrna | is related to: READNA | nlx_158236 | SCR_003901 | SciCrunch Registry | febit, febit GmbH, Comprehensive Biomarker Center Gmbh | 2026-09-26 02:13:37 | 0 | ||||||||
|
FlexGen Resource Report Resource Website 1+ mentions |
FlexGen (RRID:SCR_003902) | FlexGen | commercial organization | A biotechnology company that has developed technology for synthesizing custom microarrays, the FlexArrayer. Its is a desk-top sized instrument which allows the researcher to generate, in their own laboratory, either a custom oligonucleotide array in a single day or oligonucleotide pool in a few days. Recent developments in synthesis chemistry allows many modifications to be incorporated or for alternative chemistries to be considered., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. | biotechnology, microarray, custom oligonucleotide array, oligonucleotide pool, oligonucleotide, gene, probe synthesis, target enrichment, probe design, biomolecule, dna sequencing, oligonucleotide synthesis, re-sequencing | is related to: READNA | THIS RESOURCE IS NO LONGER IN SERVICE | nlx_158237 | SCR_003902 | SciCrunch Registry | FlexGen B.V. | 2026-09-26 02:13:35 | 6 | |||||||
|
RevMan Resource Report Resource Website 10000+ mentions |
RevMan (RRID:SCR_003581) | RevMan | software resource | THIS RESOURCE IS NO LONGER IN SERVICE. Documented on January 5, 2023.A software package that does meta-analysis and provides results in tabular format and graphically., THIS RESOURCE IS NO LONGER IN SERVICE. Documented on September 16,2025. |
is listed by: OMICtools is listed by: SoftCite |
THIS RESOURCE IS NO LONGER IN SERVICE | OMICS_00244 | SCR_003581 | SciCrunch Registry | Review Manager | 2026-09-26 02:13:30 | 12962 | ||||||||
|
Torrey Pines Biolabs Resource Report Resource Website 100+ mentions |
Torrey Pines Biolabs (RRID:SCR_003580) | commercial organization | An Antibody supplier | nlx_152481 | SCR_003580 | SciCrunch Registry | Torrey Pines Biolabs Inc., Torrey Pines Biolabs Inc | 2026-09-26 02:13:30 | 376 | |||||||||||
|
Inserm Transfert Resource Report Resource Website |
Inserm Transfert (RRID:SCR_003808) | commercial organization | A private subsidiary of the French National Institute of the Health and Medical Research (Inserm), dedicated to technology transfer (from invention disclosure to industrial partnership). It manages European and International research projects, supports large scale projects in epidemiology and public health. It has run a proof of concept fund. The company is also committed to seed financing in the biotech sector, through its dedicated seed fund company Inserm Transfert Initiative. www.inserm-transfert.fr | technology transfer, epidemiology, public health |
is related to: AgedBrainSYSBIO has parent organization: National Institute of Health and Medical Research; Rennes; France is parent organization of: AgedBrainSYSBIO |
nlx_158128, grid.14498.30 | https://ror.org/01wftfc57 | SCR_003808 | SciCrunch Registry | Inserm-Transfert SA, Inserm Transfert SA | 2026-09-26 02:13:33 | 0 | ||||||||
|
Minimum Information About a Simulation Experiment Resource Report Resource Website 1+ mentions |
Minimum Information About a Simulation Experiment (RRID:SCR_003800) | MIASE | data or information resource, narrative resource, standard specification | A set of guidelines (community effort) suitable for use with any structured format for simulation experiments to identify the Minimal Information About a Simulation Experiment necessary to enable the reproducible simulation experiments. The Guidelines list the information that a modeller needs to provide to enable the execution and reproduction of a numerical simulation experiment, derived from a given set of quantitative models. MIASE is designed to help modelers and software tools to exchange their simulation settings and to foster collaboration. In 2011, he MIASE guidelines were accepted by researchers from 19 different institutes. | simulation |
is used by: Simulation Experiment Description Markup Language is listed by: Minimum Information for Biological and Biomedical Investigations |
PMID:21552546 | nlx_158097 | SCR_003800 | SciCrunch Registry | MIASE Guidelines | 2026-09-26 02:13:35 | 2 | |||||||
|
Minimal Standard Terminology of Digestive Endoscopy - French Resource Report Resource Website |
Minimal Standard Terminology of Digestive Endoscopy - French (RRID:SCR_003830) | MSTDE-FRE | controlled vocabulary, data or information resource, ontology | Metathesaurus Version of Minimal Standard Terminology Digestive Endoscopy, French Translation, 2001 | umls | is listed by: BioPortal | nlx_157484 | SCR_003830 | SciCrunch Registry | Minimal Standard Terminology of Digestive Endoscopy French | 2026-09-26 02:13:36 | 0 | ||||||||
|
PSTC Nephrotoxicity Biomarkers Resource Report Resource Website |
PSTC Nephrotoxicity Biomarkers (RRID:SCR_003709) | PSTC Nephrotoxicity Biomarkers | data or information resource, narrative resource, standard specification | Urinary kidney biomarkers (KIM-1, albumin, total protein, 2-microglobulin, cystatin C, clusterin and trefoil factor-3) that are considered acceptable biomarkers for the detection of acute drug-induced nephrotoxicity in rats and can be included along with traditional clinical chemistry markers and histopathology in toxicology studies. These biomarkers may be used voluntarily as additional evidence of nephrotoxicity in nonclinical safety assessment studies to complement the standard data (BUN and sCr). In ROC analyses, some of these biomarkers showed better sensitivity and specificity than BUN and sCr relative to histopathological alterations considered to be the gold standard when tested with a limited number of nephrotoxicant and control compounds. | biomarker, drug development, drug, urinary, urinary biomarker, gold standard, kim-1, albumin, total protein, beta2-microglobulin, cystatin c, clusterin, trefoil factor-3, kidney, nonclinical |
is recommended by: U.S. Food and Drug Administration has parent organization: Drug Development Tools Qualification Programs has parent organization: Predictive Safety Testing Consortium |
Nephrotoxicity, Drug-induced nephrotoxicity | Public | nlx_157890 | SCR_003709 | SciCrunch Registry | Predictive Safety and Testing Consortium Drug-induced Nephrotoxicity Biomarkers, PSTC NWG Drug-induced Nephrotoxicity Biomarkers | 2026-09-26 02:13:31 | 0 | ||||||
|
Antilope Project Resource Report Resource Website 1+ mentions |
Antilope Project (RRID:SCR_003829) | Antilope | consortium, data or information resource, narrative resource, organization portal, portal, standard specification | Consortium focused on making electronic health data more interoperable, both within and outside of Europe, with the intention to create, validate, and disseminate standard methods to test and certify electronic health solutions and services. In particular it will: Drive the adoption of recognized sets of profiles and underlying standards for eHealth interoperability, and improve the impact of the EU and International eHealth standards development process; Define and validate testing guidelines and common approaches on Interoperability Labelling and Certification processes at European and at National / Regional level. Four work packages were created to provide guidelines, recommendations and frameworks based on a set of use cases, related profiles and standards, Interoperability Quality Management System, testing guidelines and Certification process. All the deliverables will be presented for validation and promotion by organizing workshops across Europe. | consortium, interoperability, electronic health data, data sharing, testing, certification, ehealth | is listed by: Consortia-pedia | European Union FP7 325077 | nlx_158143 | SCR_003829 | SciCrunch Registry | 2026-09-26 02:13:33 | 1 | ||||||||
|
Selleck Chemicals LLC Resource Report Resource Website 100+ mentions |
Selleck Chemicals LLC (RRID:SCR_003823) | commercial organization | An Antibody supplier | antibody, chemical supply, selleck chemicals | nlx_152457 | SCR_003823 | SciCrunch Registry | Selleck Chemicals | 2026-09-26 02:13:33 | 235 | ||||||||||
|
Medical University of South Carolina; South Carolina; USA Resource Report Resource Website 1+ mentions |
Medical University of South Carolina; South Carolina; USA (RRID:SCR_003828) | MUSC | university | Public medical school in Charleston, South Carolina. Opened in 1824 as small private college aimed at training physicians. One of the oldest continually operating schools of medicine in the United States and the oldest in the Deep South. |
is affiliated with: NIH StrokeNet is related to: Clinical and Translational Science Awards Consortium is parent organization of: MUSC Health News is parent organization of: Hollings Cancer Center Tissue Biorepository and Research Pathology Services Shared Resource is parent organization of: SPARC Request is parent organization of: Medical University of South Carolina Department of Cell and Molecular Pharmacology and Experimental Therapeutics is parent organization of: Medical University of South Carolina Center on Aging is parent organization of: MUSC Health Podcast Library is parent organization of: Charleston Heart Study is parent organization of: Diffusional Kurtosis Estimator is parent organization of: ArrayQuest is parent organization of: MUSC DNA Microarray Database is parent organization of: NiiStat is parent organization of: MRIcroS is parent organization of: Medical University of South Carolina College of Dental Medicine Gnotobiotic Animal Core Facility is parent organization of: University of South Carolina Electron Microscopy Core Facility is parent organization of: Medical University of South Carolina Hollings Cancer Center Cell and Molecular Imaging Core Facility is parent organization of: Medical University of South Carolina MUSC Mouse Behavior Phenotyping Core Facility is parent organization of: Medical University of South Carolina AI High Performance Computing Core |
GRID grid.259828.c, , nlx_34109, Wikidata Q6806451, ISNI 0000 0001 2189 3475, Crossref Funder ID 100006942 | https://ror.org/012jban78 | SCR_003828 | SciCrunch Registry | Medical University of South Carolina | 2026-09-26 02:13:33 | 3 | ||||||||
|
Academic Drug Discovery Consortium Resource Report Resource Website 1+ mentions |
Academic Drug Discovery Consortium (RRID:SCR_003706) | ADDC, aD2c | consortium, data or information resource, organization portal, portal | A collaborative network among university-led drug discovery centers and programs to allow scientists to exchange technical expertise on drug discovery and development strategies as well as form partnerships with each other, biopharma companies, and drug discovery-focused contract service organizations and consultants. The website will also serve as a repository for drug discovery events, educational material, job postings, and partnership opportunities. Through active member participation this website will become a valuable tool for every scientist working in the drug discovery arena. In addition, involvement of members will enable them to effectively advocate to the NIH and other funding agencies to increase the awareness of the growing number of academic drug discovery scientists and their success as well as their needs. | drug, consortium, drug discovery |
is listed by: Consortia-pedia has parent organization: Johns Hopkins University; Maryland; USA |
SciRes_000146, nlx_157873 | SCR_003706 | SciCrunch Registry | Academic Drug Discovery Consortium (ADDC) | 2026-09-26 02:13:31 | 4 | ||||||||
|
AirPROM Resource Report Resource Website |
AirPROM (RRID:SCR_003827) | AirPROM | consortium, data or information resource, organization portal, portal | Consortium focused on developing computer and physical models of the airway system for patients with asthma and chronic obstructive pulmonary disease (COPD). Developing accurate models will better predict how asthma and COPD develop, since current methods can only assess the severity of disease. They aim to bridge the gaps in clinical management of airways-based disease by providing reliable models that predict disease progression and the response to treatment for each person with asthma or COPD. A data management platform provides a secure and sustainable infrastructure that semantically integrates the clinical, physiological, genetic, and experimental data produced with existing biomedical knowledge from allied consortia and public databases. This resource will be available for analysis and modeling, and will facilitate sharing, collaboration and publication within AirPROM and with the broader community. Currently the AirPROM knowledge portal is only accessible by AirPROM partners. | model, airway system, lung, consortium, clinical, imaging, respiratory system, tissue sample, airway model, genomic, gas diffusion mri, airway development, function, physiological, genetic, computational model, gene-environment interaction |
is listed by: Consortia-pedia has parent organization: European Lung Foundation |
European Union FP7 | nlx_158142 | SCR_003827 | SciCrunch Registry | Airway Disease Predicting Outcomes through Patient Specific Computational Modelling | 2026-09-26 02:13:33 | 0 | |||||||
|
Quretec Resource Report Resource Website 1+ mentions |
Quretec (RRID:SCR_003826) | Quretec | commercial organization | Commercial organization that builds software for collection, management, and analysis of complex data, most typical in biomedical domain. The solutions are generic and can be used for multitude of uses and application domains. | data capture, data management, analysis, biomedical | is related to: AgedBrainSYSBIO | Wikidata: Q30291134, grid.436973.c, nlx_158133 | https://ror.org/02ca38p84 | SCR_003826 | SciCrunch Registry | Quretec Ltd., Quretec Ltd | 2026-09-26 02:13:36 | 2 | |||||||
|
AgedBrainSYSBIO Resource Report Resource Website 1+ mentions |
AgedBrainSYSBIO (RRID:SCR_003825) | AgedBrainSYSBIO | consortium, data or information resource, organization portal, portal | Consortium focused on identifying the foundational pathways responsible for the aging of the brain, with a focus on Late Onset Alzheimer's disease. They aim to identify the interactions through which the aging phenotype develops in normal and in disease conditions; modeling novel pathways and their evolutionary properties to design experiments that identify druggable targets. As early steps of neurodegenerative disorders are expected to impact synapse function the project will focus in particular on pre- or postsynaptic protein networks. The concept is to identify subsets of pathways with two unique druggable hallmarks, the validation of interactions occurring locally in subregions of neurons and a human and/or primate accelerated evolutionary signature. The consortium will do this through six approaches: * identification of interacting protein networks from recent Late-Onset Alzheimer Disease-Genome Wide Association Studies (LOAD-GWAS) data, * experimental validation of interconnected networks working in subregion of a neuron (such as dendrites and dendritic spines), * inclusion of these experimentally validated networks in larger networks obtained from available databases to extend possible protein interactions, * identification of human and/or primate positive selection either in coding or in regulatory gene sequences, * manipulation of these human and/or primate accelerated evolutionary interacting proteins in human neurons derived from induced Pluripotent Stem Cells (iPSCs) * modeling predictions in drosophila and novel mouse transgenic models * validation of new druggable targets and markers as a proof-of-concept towards the prevention and cure of aging cognitive defects. The scientists will share results and know-how on Late-Onset Alzheimer Disease-Genome Wide Association Studies (LOAD-GWAS) gene discovery, comparative functional genomics in mouse and drosophila models, in mouse transgenic approaches, research on human induced pluripotent stem cells (hiPSC) and their differentiation in vitro and modeling pathways with emphasis on comparative and evolutionary aspects. The four European small to medium size enterprises (SMEs) involved will bring their complementary expertise and will ensure translation of project results to clinical application. | consortium, drug, drug development, brain, phenotype, presynaptic, protein network, postsynaptic, systems biology, synapse, neuron, protein interaction, network, induced pluripotent stem cell, pathway, genome wide association study, cognitive defect, gene, protein |
is listed by: Consortia-pedia is related to: Pasteur Institute of Lille; Lille; France is related to: Mouse Clinical Institute; Alsace; France is related to: Hybrigenics is related to: Inserm Transfert is related to: VIB; Flanders; Belgium is related to: Quretec is related to: Gene Bridges is related to: European Bioinformatics Institute is related to: Tel Aviv University; Ramat Aviv; Israel is related to: SIB Swiss Institute of Bioinformatics is related to: Babraham Institute has parent organization: National Institute of Health and Medical Research; Rennes; France has parent organization: Inserm Transfert |
European Union FP7 305299 | nlx_158132 | SCR_003825 | SciCrunch Registry | 2026-09-26 02:13:33 | 3 | ||||||||
|
European Federation of Pharmaceutical Industries and Associations Resource Report Resource Website 10+ mentions |
European Federation of Pharmaceutical Industries and Associations (RRID:SCR_003820) | EFPIA | institution | Federation representing the pharmaceutical industry operating in Europe. Through its direct membership of 33 national associations and 40 leading pharmaceutical companies, it is the voice on the EU scene of 1,900 companies committed to researching, developing and manufacturing new medical treatments. In addition, it is active in partnering in EU Research programmes, such as the IMI (Innovative Medicines Initiative), Europe's largest public-private partnerships. They also work on corporate social responsibility initiatives with others healthcare stakeholders, such as patient groups and healthcare professionals. EFPIA has specialized committees and task forces focused on key areas of activity. EFPIA also includes two specialized groups focusing on vaccines and biotechnology, respectively: * Vaccines Europe (formerly European Vaccine Manufacturers, EVM) produces approximately 80% of vaccines used worldwide * European Biopharmaceutical Enterprises (EBE) harness biotechnology to develop approximately one-fifth of new medicines | pharmaceutical, medicine, vaccine, biotechnology, manufacturing, corporate |
is affiliated with: Merck is affiliated with: Roche is related to: Innovative Medicines Initiative is parent organization of: Innovative Medicines Initiative |
grid.484123.8, nlx_158124, ISNI: 0000 0000 9246 8110, Wikidata: Q1376562 | https://ror.org/00g1x4v36 | SCR_003820 | SciCrunch Registry | 2026-09-26 02:13:33 | 20 | ||||||||
|
BioSHaRE Resource Report Resource Website 10+ mentions |
BioSHaRE (RRID:SCR_003811) | BIOSHARE-EU | consortium, data or information resource, narrative resource, organization portal, portal, standard specification | A consortium of leading biobanks and international researchers from all domains of biobanking science to ensure the development of harmonized measures and standardized computing infrastructures enabling the effective pooling of data and key measures of life-style, social circumstances and environment, as well as critical sub-components of the phenotypes associated with common complex diseases. The overall aim is to build upon tools and methods available to achieve solutions for researchers to use pooled data from different cohort and biobank studies. This, in order to obtain the very large sample sizes needed to investigate current questions in multifactorial diseases, notably on gene-environment interactions. This aim will be achieved through the development of harmonization and standardization tools, implementation of these tools and demonstration of their applicability. BioSHaRE researchers are collaborating with P3G, the Global Alliance for Genomics and Health, IRDiRC (International Rare Diseases Research Consortium), H3Africa and other organizations on the development of an International Code of Conduct for Genomic and Health-Related Data Sharing. A draft version is available for external review. Generic documents have been prepared covering areas of biobanking that are of major importance. SOPs have been finalized for blood withdrawal (SOPWP5001blood withdrawal), manual blood processing (SOPWP5002blood processing), shipping of biosamples (SOPWP5003shipping) and withdrawal, processing and storage of urine samples (SOPWP5004urine). | gene-environment interaction, life-style, social circumstance, environment, phenotype, disease, biobank, socio-economic factor, data sharing, gene, clinical |
is listed by: Consortia-pedia has parent organization: University of Groningen; Groningen; Netherlands is parent organization of: BioResource Impact Factor |
European Union FP7 | nlx_158110 | SCR_003811 | SciCrunch Registry | Biobank Standardisation and Harmonisation for Research Excellence, Biobank Standardisation and Harmonisation for Research Excellence in the European Union | 2026-09-26 02:13:35 | 22 | |||||||
|
Asthma UK Resource Report Resource Website 10+ mentions |
Asthma UK (RRID:SCR_003815) | Asthma UK | institution | Charity that aims to significantly reduce the number of asthma deaths, hospitalizations and living lives compromised by asthma helping over five million people with asthma in the UK through research, campaigning, health promotion and engagement with the asthma community. Asthma UK is a significant investor in asthma research within the UK and to date has invested over 50 million pounds into research for better treatments and ultimately a cure for asthma. | lung, treatment | is parent organization of: EARIP | Asthma | Crossref funder ID: 501100000362, ISNI: 0000 0000 9981 854X, nlx_158172, grid.453156.0 | https://ror.org/03z7xev21 | SCR_003815 | SciCrunch Registry | 2026-09-26 02:13:33 | 13 | |||||||
|
EURORDIS Resource Report Resource Website 10+ mentions |
EURORDIS (RRID:SCR_003814) | EURORDIS | nonprofit organization | EURORDIS is a non-governmental patient-driven alliance of patient organizations and individuals active in the field of rare diseases, dedicated to improving the quality of life of all people living with rare diseases in Europe. It is a not-for-profit organization and represents more than 479 rare disease organizations in 45 different countries (of which 25 are EU Member States), covering more than 4,000 rare diseases. It is therefore the voice of the 30 million patients affected by rare diseases throughout Europe. EURORDIS aims at improving the quality of life of people living with rare diseases in Europe through advocacy at the European level, support for research and drug development, networking patient groups, raising awareness and other actions designed to fight against the impact of rare diseases on the lives of patients and family. EURORDIS' training programs and resources are designed to strengthen the capacity of rare disease patients' representatives. Training empowers patients' representatives to advocate effectively for rare diseases at both the local and EU level. Key issues affecting patients of Rare Diseases on which we actively work: * Sustaining rare diseases as an EU public health priority * Making Rare Diseases A Public Health Priority In All Member States * Rare Diseases: An International Public Health Priority * Improving Access To Orphan Drugs * Improving Access To Quality Care * Promoting cross-border healthcare and patient mobility * Bridging Patients And Research * Genetic testing and newborn screening | French Muscular Dystrophy Association ; European Union ; members ; corporate foundations ; health industry |
Wikidata: Q5412882, grid.433753.5, nlx_143535 | https://ror.org/019w4mg02 | SCR_003814 | SciCrunch Registry | EURORDIS - Rare Diseases Europe | 2026-09-26 02:13:33 | 40 |
Can't find your Tool?
We recommend that you click next to the search bar to check some helpful tips on searches and refine your search firstly. Alternatively, please register your tool with the SciCrunch Registry by adding a little information to a web form, logging in will enable users to create a provisional RRID, but it not required to submit.
Welcome to the dkNET Resources search. From here you can search through a compilation of resources used by dkNET and see how data is organized within our community.
You are currently on the Community Resources tab looking through categories and sources that dkNET has compiled. You can navigate through those categories from here or change to a different tab to execute your search through. Each tab gives a different perspective on data.
If you have an account on dkNET then you can log in from here to get additional features in dkNET such as Collections, Saved Searches, and managing Resources.
Here is the search term that is being executed, you can type in anything you want to search for. Some tips to help searching:
If you are logged into dkNET you can add data records to your collections to create custom spreadsheets across multiple sources of data.
Here are the facets that you can filter the data by.
If you have any further questions please check out our FAQs Page to ask questions and see our tutorials. Click this button to view this tutorial again.
The NIDDK Information Network (dkNET) serves the needs of basic and clinical investigators by providing seamless access to large pools of data and research resources relevant to the mission of The National Institute of Diabetes Digestive and Kidney Diseases (NIDDK). dkNET is hosted at University of California San Diego, and is supported by NIH NIDDK grant U24DK097771.
Email: info_at_ dknet.org
